The Taizhou Medical High-tech Zone – located in Taizhou city, Jiangsu province – is safeguarding the share market listings of resident companies.
The zone is placing the promotion of enterprise listings in a prominent position and is accelerating the pace of their flotations and capital operations.
In 2021, the zone released the latest Implementation Opinions on Promoting Enterprise Listing, providing all-round supports such as encouraging enterprises to reform into joint-stock companies, listing both domestically and internationally, and supporting their sustainable development.
The rewards for enterprise listing and initial financing were increased from a maximum of 5.6 million yuan ($770,437) previously to 6.7 million yuan.
In 2021, the China Medical City Listed Enterprise Alliance was established in the zone, jointly founded by over ten listed and planned listed companies to foster enterprise information sharing and collaborative construction.
In addition, the zone has regularly organized financing roadshow activities to boost the matchmaking of capital and companies. This has facilitated over 30 companies to achieve phased equity financing of nearly 8.5 billion yuan.
One-to-one services are also granted by the zone to help companies solve problems in their process of going public. For example, during the listing period of Qyuns Therapeutics Co Ltd, the zone succeeded in helping it solve the problem of overseas investment filing for cornerstone investors.
A view of Taizhou Medical High-tech Zone. [Photo/Taizhou Medical High-tech Zone via WeChat weigg6666]